Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

BTK Inhibitors Versus Venetoclax as First‐ or Second‐Line Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real‐World Evidence Study

American Journal of Hematology(2025)10.1002/ajh.27639Source: DataRank Database

BTK Inhibitors Versus Venetoclax as First‐ or Second‐Line Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real‐World Evidence Study is a research paper published in American Journal of Hematology (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.54)OA: hybridTopics (19)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Yi Han ORCID,Anna Teschemaker,Anthony R. Mato ORCID,Meghan C. Thompson ORCID,Lindsey E. Roeker ORCID

Live enrichment

PubMed:39960132 PMC:PMC11886488 OpenAlex:https://openalex.org/W4407649828

National Institutes of Health

Grant: P30 CA008748

AstraZeneca

FWCI

1.54

Citation Percentile

0.8%

Citation Trend

2025

2026

hybridLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.27639

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.27639

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27639

journalhttps://doi.org/10.1002/ajh.27639

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39960132

Fields of Study

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Myeloid Leukemia Treatments

Keywords

VenetoclaxChronic lymphocytic leukemiaMedicineIbrutinibLymphomaBruton's tyrosine kinaseLeukemiaImmunologyOncologyCancer researchInternal medicineReceptorTyrosine kinaseSmall Lymphocytic LymphomaBruton Tyrosine Kinase InhibitorReal‐world Evidence